Dawn Anderson

Dawn Anderson is a managing director in Deloitte’s Life Sciences, R&D Practice. She has more than 30 years of industry and consulting experience in pharmaceutical, biotechnology, MedTech, CROs and technology companies. Her practice is focused on clinical development, and she works with biopharma and CRO clients to design and deploy global operating strategy, performance improvement, and technology implementations across drug development.